Evidence map›Paper›PMID 35087272›Full record

ArticleInternational journal of nanomedicine2022

Effects of Nanoceria on Human Platelet Functions and Blood Coagulation.

Jyotsna Kailashiya, Debabrata Dash

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jyotsna KailashiyaCentre for Advanced Research on Platelet Signalling & Thrombosis Biology, Department of Biochemistry, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.ORCID 0000-0002-1631-0084
Debabrata DashCentre for Advanced Research on Platelet Signalling & Thrombosis Biology, Department of Biochemistry, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.ORCID 0000-0001-7291-2453
Institute of Medical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCerium oxide nanoparticles (nanoceria) exist in either 3+ or 4+ oxidation state with interesting redox properties and exhibit both oxidant and antioxidant attributes based on concentration, environment and pH. Thanks to their wide spread use in fuel, cosmetics and other industries as well as in biomedical field, nanoceria particles get released into environment with risk of significant human exposure, and thus necessitate careful examination and optimization of their biomedical applications.

methodsThis research was planned to explore effects of nanoceria on human platelet functions and whole blood coagulation. Platelets and whole blood from volunteer healthy donors were treated with different doses of nanoceria and various platelet functions, fibrin polymerization and blood coagulation were tested.

resultsNanoceria particles were found to reduce platelet aggregation and secretion of granule contents in a dose-dependent manner, impaired fibrin polymerization and retraction of fibrin-rich thrombi, associated with reduced cytosolic filamentous actin. Remarkably, nanoceria instigated early clot formation in whole blood attributable to putative activation of coagulation cascade.

conclusionAbove observations provide cautionary framework to critically re-evaluate and accordingly plan biomedical applications of nanoceria.

Indexed as

CeriumNanoparticlesBlood CoagulationBlood PlateletsHumansceric oxideCeriumcerium oxide nanoparticlesfibrin polymerizationhuman plateletsplatelet aggregationthromboelastogram

Identifiers

PMID35087272
PMCPMC8789318
OpenAlexW4205905957

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.